BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17919326)

  • 1. The 2G allele of promoter region of matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma.
    Nishizawa R; Nagata M; Noman AA; Kitamura N; Fujita H; Hoshina H; Kubota T; Itagaki M; Shingaki S; Ohnishi M; Kurita H; Katsura K; Saito C; Yoshie H; Takagi R
    BMC Cancer; 2007 Oct; 7():187. PubMed ID: 17919326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population.
    Cao ZG; Li CZ
    Oral Oncol; 2006 Jan; 42(1):32-8. PubMed ID: 16256416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas.
    Lin SC; Chung MY; Huang JW; Shieh TM; Liu CJ; Chang KW
    J Oral Pathol Med; 2004 Jul; 33(6):323-6. PubMed ID: 15200479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma.
    Vairaktaris E; Yapijakis C; Derka S; Serefoglou Z; Vassiliou S; Nkenke E; Ragos V; Vylliotis A; Spyridonidou S; Tsigris C; Yannopoulos A; Tesseromatis C; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(1A):459-64. PubMed ID: 17352267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer].
    Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
    Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of
    Hsiao CL; Liu LC; Shih TC; Lai YL; Hsu SW; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Su CH; Way TD; Chung JG; Bau DT
    In Vivo; 2018; 32(3):487-491. PubMed ID: 29695550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis.
    Ghilardi G; Biondi ML; DeMonti M; Turri O; Guagnellini E; Scorza R
    Stroke; 2002 Oct; 33(10):2408-12. PubMed ID: 12364729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
    Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
    Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of a single nucleotide polymorphism and allelic imbalance of matrix metalloproteinase-1 promoter region in prostate cancer.
    Tsuchiya N; Narita S; Kumazawa T; Inoue T; Ma Z; Tsuruta H; Saito M; Horikawa Y; Yuasa T; Satoh S; Ogawa O; Habuchi T
    Oncol Rep; 2009 Sep; 22(3):493-9. PubMed ID: 19639194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
    Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P
    Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Variants with Ischemic Stroke and Its Subtype.
    Huang XY; Han LY; Huang XD; Guan CH; Mao XL; Ye ZS
    J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):368-375. PubMed ID: 27793533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional polymorphism (-1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer.
    Liu L; Wu J; Wu C; Wang Y; Zhong R; Zhang X; Tan W; Nie S; Miao X; Lin D
    Cancer; 2011 Nov; 117(22):5172-81. PubMed ID: 21523769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.
    Gantala SR; Kondapalli MS; Kummari R; Padala C; Tupurani MA; Kupsal K; Galimudi RK; Gundapaneni KK; Puranam K; Shyamala N; Guditi S; Rapur R; Hanumanth SR
    Gene; 2018 Oct; 673():22-31. PubMed ID: 29883760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase (MMP)-1 and MMP-3 gene variations affect MMP-1 and -3 serum concentration and associates with breast cancer.
    Balkhi S; Mashayekhi F; Salehzadeh A; Saedi HS
    Mol Biol Rep; 2020 Dec; 47(12):9637-9644. PubMed ID: 33170424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
    Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
    Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China.
    Jin X; Kuang G; Wei LZ; Li Y; Wang R; Guo W; Wang N; Fang SM; Wen DG; Chen ZF; Zhang JH
    World J Gastroenterol; 2005 Apr; 11(16):2385-9. PubMed ID: 15832405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China.
    Lu Z; Cao Y; Wang Y; Zhang Q; Zhang X; Wang S; Li Y; Xie H; Jiao B; Zhang J
    J Neurooncol; 2007 Oct; 85(1):65-73. PubMed ID: 17502998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.